
May 13 (Reuters) - Leap Therapeutics Inc LPTX.O:
LEAP THERAPEUTICS Q1 NET INCOME USD -15.435 MILLION
LEAP THERAPEUTICS Q1 OPERATING INCOME USD -15.917 MILLION
LEAP THERAPEUTICS Q1 OPERATING EXPENSES USD 15.917 MILLION
LEAP THERAPEUTICS Q1 EPS USD -0.37
LEAP THERAPEUTICS INC: HAS REDUCED ITS WORKFORCE BY APPROXIMATELY 50%
LEAP THERAPEUTICS INC: STRATEGIC RESTRUCTURING TO PRIORITIZE CLINICAL FOCUS ON DEVELOPMENT OF SIREXATAMAB IN CRC